Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "K-Nithyananda-Reddy"

8 News Found

Aurobindo Pharma Q3 FY23 net profit down 18.7% at Rs 491 Crores
News | February 10, 2023

Aurobindo Pharma Q3 FY23 net profit down 18.7% at Rs 491 Crores

Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.


Aurobindo Pharma Foundation distributes 15 tri motor bikes to physically challenged persons at Jadcherla, Telangana
News | June 27, 2022

Aurobindo Pharma Foundation distributes 15 tri motor bikes to physically challenged persons at Jadcherla, Telangana

Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.


Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
News | June 06, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore


Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation
Sustainability | April 22, 2022

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation

A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh


Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme
Sustainability | March 06, 2022

Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme

With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle


Aurobindo Pharma rolls out Molnaflu in India
News | January 06, 2022

Aurobindo Pharma rolls out Molnaflu in India

The brand is now available pan-India through their distribution partner


Aurobindo to manufacture and market molnupiravir
Drug Approval | December 28, 2021

Aurobindo to manufacture and market molnupiravir

The drug will be marketed under the brand name Molnaflu


Aurobindo subsidiary submits MAA for oncology biosimilar
Biotech | September 23, 2021

Aurobindo subsidiary submits MAA for oncology biosimilar

CuraTeQ Biologics is on track for filing a second oncology biosimilar